Literature DB >> 7448797

Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages.

A Raz, C Bucana, W E Fogler, G Poste, I J Fidler.   

Abstract

The interaction of multilamellar liposomes with mouse peritoneal macrophages cultured in vitro has been examined. The principal mechanism of liposome uptake by these cells is by phagocytic engulfment. Studies with radiolabeled liposomes demonstrated that they are incorporated into macrophages as intact structures and that treatment of macrophages with inhibitors of phagocytosis prevents liposome uptake. Incubation of macrophages with liposomes containing encapsulated fluorescein-labeled bovine serum albumin resulted in localization of fluorescence within discrete cytoplasmic vacuoles. Ultrastructural observations confirmed that liposomes were internalized and were enclosed within phagosomes. Electron microscopy also revealed that, by 24 hr following phagocytosis, adjacent phagosomes containing liposomes prepared from bovine brain phosphatidylserine, egg phosphatidylcholine, and lysolecithin (mol ratio, 4.95/4.95/0.1) fused within the cytoplasm. In contrast, phagosomes containing neutral liposomes consisting solely of egg phosphatidylcholine did not fuse and remained as discrete single structures. Negatively charged bovine brain phosphatidylserine/egg phosphatidylcholine/lysolecithin liposomes were phagocytosed at a much faster rate (12 times faster) than were neutral egg phosphatidylcholine liposomes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7448797

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Treating metastatic cancer with nanotechnology.

Authors:  Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

2.  Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

Review 3.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

Review 4.  Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles.

Authors:  Esmaiel Jabbari
Journal:  Pharm Res       Date:  2008-12-17       Impact factor: 4.200

5.  Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation.

Authors:  J Connor; C Bucana; I J Fidler; A J Schroit
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Liposomal simvastatin attenuates neointimal hyperplasia in rats.

Authors:  Eyal Afergan; Meital Ben David; Hila Epstein; Nickolay Koroukhov; Dalia Gilhar; Keren Rohekar; Haim D Danenberg; Gershon Golomb
Journal:  AAPS J       Date:  2010-02-09       Impact factor: 4.009

7.  Unilamellar liposomes modulate secretion of tumor necrosis factor by lipopolysaccharide-stimulated macrophages.

Authors:  G F Brisseau; A Kresta; D Schouten; J M Bohnen; P N Shek; E Fok; O D Rotstein
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

Review 8.  Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.

Authors:  I J Fidler; G Poste
Journal:  Springer Semin Immunopathol       Date:  1982

9.  The systemic activation of macrophages by liposomes containing immunomodulators.

Authors:  R Nayar; I J Fidler
Journal:  Springer Semin Immunopathol       Date:  1985

Review 10.  Biological rationale for the design of polymeric anti-cancer nanomedicines.

Authors:  Yan Zhou; Jindřich Kopeček
Journal:  J Drug Target       Date:  2012-09-26       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.